Catalisano Giulia, Campione Gioacchina Martina, Spurio Giulia, Galvano Alberto Nicolò, di Villalba Cesira Palmeri, Giarratano Antonino, Alongi Antonietta, Ippolito Mariachiara, Cortegiani Andrea
Department of Precision Medicine in Medical Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, Palermo, Italy.
Department of Anesthesia Intensive Care and Emergency, University Hospital Policlinico 'Paolo Giaccone', Via del Vespro 129, 90127, Palermo, Italy.
J Anesth Analg Crit Care. 2024 Sep 27;4(1):67. doi: 10.1186/s44158-024-00204-z.
Neuropathic pain (NP) is a chronic and disabling condition, caused by a lesion or disease of the somatosensory nervous system, characterized by a systemic inflammatory state. Signs and associated symptoms are rarely recognized, and response to usual analgesic drugs is poor. Antidepressant drugs are first-line agents for the treatment of NP. This narrative review aims to summarize the role of antidepressant drugs in treating NP and their mechanism of action, focusing on the effects on inflammatory cytokines.
Peripheral nerve injury leads to a local inflammatory response and to the disruption of the blood-medullary barrier, allowing the influx of peripheral immune cells into the central nervous system. Antidepressants have antinociceptive effects because they recruit long-term neuronal plasticity. Amitriptyline modulates the inflammatory response due to the reduction of the mRNA of pro-inflammatory cytokines acting as an adenosine agonist and leading to the activation of the AAR receptor. Through toll-like receptors, local inflammation determines the release of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) that drives and stimulates the hyperflammation in NP. Nortriptyline has an important antiallodynic effect in NP as it determines the recruitment of norepinephrine in the dorsal root ganglia. By modulating the β2-adrenoreceptors expressed by non-neuronal satellite cells, it inhibits the local production of TNF-α and determines a reduction of NP symptoms. Following the administration of antidepressants, there is a reduction in the production of TNF-α in the brain which in turn transforms the function of the α2-adrenergic receptor from an inhibitor to an activator of the release of norepinephrine. This is important to prevent the development of chronic pain.
Inflammatory cytokines are the main players in a bidirectional communication between the central and peripheral nervous system and the immune system in NP. Antidepressants have an important role in NP. Further research should explore the interaction between neuroinflammation in NP, the effects of antidepressants and the clinical relevance of this interaction.
神经性疼痛(NP)是一种慢性致残性疾病,由躯体感觉神经系统的损伤或疾病引起,其特征为全身性炎症状态。其体征和相关症状很少被识别,对常用镇痛药的反应不佳。抗抑郁药是治疗NP的一线药物。本叙述性综述旨在总结抗抑郁药在治疗NP中的作用及其作用机制,重点关注对炎性细胞因子的影响。
外周神经损伤会导致局部炎症反应以及血髓屏障的破坏,使外周免疫细胞流入中枢神经系统。抗抑郁药具有抗伤害感受作用,因为它们能引发长期的神经元可塑性。阿米替林通过减少作为腺苷激动剂的促炎细胞因子的mRNA来调节炎症反应,并导致AAR受体的激活。局部炎症通过Toll样受体决定促炎细胞因子如肿瘤坏死因子-α(TNF-α)的释放,TNF-α会驱动并刺激NP中的过度炎症。去甲替林在NP中具有重要的抗痛觉过敏作用,因为它能促使去甲肾上腺素在背根神经节中募集。通过调节非神经元卫星细胞表达的β2-肾上腺素能受体,它抑制TNF-α的局部产生并减轻NP症状。服用抗抑郁药后,大脑中TNF-α的产生减少,这反过来又将α2-肾上腺素能受体的功能从去甲肾上腺素释放的抑制剂转变为激活剂。这对于预防慢性疼痛的发展很重要。
炎性细胞因子是NP中中枢和外周神经系统与免疫系统之间双向通讯的主要参与者。抗抑郁药在NP中具有重要作用。进一步的研究应探索NP中的神经炎症、抗抑郁药的作用以及这种相互作用的临床相关性之间的相互作用。